Stay updated on ABP 654 for Psoriasis: Moderate-Severe Clinical Trial

Sign up to get notified when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page Revision is updated to v3.5.3, replacing v3.5.2. This indicates a minor metadata update without altering visible content.
    Difference
    0.0%
    Check dated 2026-04-30T15:45:38.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:36:15.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T16:45:32.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Page revision updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T14:22:33.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Minor UI update: Revision v3.4.2 replaces v3.4.1 in the page footer, with no changes to study content, eligibility criteria, or results data — To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-11T01:53:58.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 with no user-facing changes to study details or page content.
    Difference
    0.0%
    Check dated 2026-02-04T01:11:37.000Z thumbnail image

Stay in the know with updates to ABP 654 for Psoriasis: Moderate-Severe Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.